tiprankstipranks
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
:8189
Hong Kong Market
8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
RESEARCH TOOLSreports

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Ratios

2 Followers

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Ratios

HK:8189's free cash flow for Q2 2025 was ¥0.06. For the 2025 fiscal year, HK:8189's free cash flow was decreased by ¥ and operating cash flow was ¥-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.75 0.84 0.88 0.88 1.09
Quick Ratio
 0.19 0.57 0.46 0.55 0.70
Cash Ratio
 0.12 0.09 0.03 0.03 0.14
Solvency Ratio
 -0.33 -0.06 -0.04 -0.05 -0.14
Operating Cash Flow Ratio
 -0.39 -0.09 -0.06 -0.06 -0.03
Short-Term Operating Cash Flow Coverage
 -0.97 -0.20 -0.21 -0.20 -0.16
Net Current Asset Value
¥ -72.52M¥ -70.09M¥ -48.36M¥ -60.41M¥ -28.49M
Leverage Ratios
Debt-to-Assets Ratio
 0.41 0.48 0.28 0.30 0.26
Debt-to-Equity Ratio
 8.98 7.22 1.67 1.46 0.90
Debt-to-Capital Ratio
 0.90 0.88 0.63 0.59 0.47
Long-Term Debt-to-Capital Ratio
 0.00 0.40 0.17 0.00 0.06
Financial Leverage Ratio
 21.67 15.01 6.07 4.81 3.45
Debt Service Coverage Ratio
 -0.14 -0.14 0.09 -0.03 -0.64
Interest Coverage Ratio
 -4.61 -6.20 -1.90 -3.81 -3.36
Debt to Market Cap
 0.19 0.28 0.42 0.19 0.18
Interest Debt Per Share
 0.05 0.09 0.05 0.06 0.05
Net Debt to EBITDA
 -5.82 -6.66 16.19 -42.29 -2.14
Profitability Margins
Gross Profit Margin
6.82%4.40%5.37%3.67%9.57%
EBIT Margin
-3.34%-7.36%-1.72%-4.37%-8.26%
EBITDA Margin
-2.67%-5.24%1.20%-0.56%-6.27%
Operating Profit Margin
-3.34%-7.36%-2.47%-6.05%-3.86%
Pretax Profit Margin
-21.46%-9.91%-3.02%-5.96%-9.41%
Net Profit Margin
-17.26%-7.21%-5.07%-6.80%-8.87%
Continuous Operations Profit Margin
-21.58%-9.85%-2.76%-5.83%-9.40%
Net Income Per EBT
80.41%72.77%167.82%114.12%94.24%
EBT Per EBIT
641.75%134.60%122.14%98.53%243.83%
Return on Assets (ROA)
-33.75%-8.36%-6.65%-8.14%-12.16%
Return on Equity (ROE)
-157.13%-125.52%-40.36%-39.15%-41.93%
Return on Capital Employed (ROCE)
-133.11%-53.09%-11.38%-20.53%-11.82%
Return on Invested Capital (ROIC)
-15.17%-14.88%-6.00%-12.83%-9.15%
Return on Tangible Assets
-33.75%-8.70%-6.95%-8.81%-12.66%
Earnings Yield
-17.25%-5.13%-11.86%-8.21%-16.11%
Efficiency Ratios
Receivables Turnover
 28.38 35.63 45.35 12.67 14.85
Payables Turnover
 21.64 41.26 23.38 20.91 14.59
Inventory Turnover
 3.39 4.89 4.16 5.85 5.73
Fixed Asset Turnover
 6.90 3.92 3.99 3.41 3.81
Asset Turnover
 1.96 1.16 1.31 1.20 1.37
Working Capital Turnover Ratio
 -31.85 -10.77 -15.40 -95.56 11.54
Cash Conversion Cycle
 103.53 75.99 80.10 73.69 63.29
Days of Sales Outstanding
 12.86 10.24 8.05 28.81 24.58
Days of Inventory Outstanding
 107.54 74.59 87.66 62.34 63.74
Days of Payables Outstanding
 16.87 8.85 15.61 17.46 25.02
Operating Cycle
 120.40 84.83 95.71 91.15 88.32
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.05 -0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 -0.05 -0.02 >-0.01 -0.01 -0.02
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.02
Free Cash Flow to Operating Cash Flow
 1.01 1.10 1.19 1.69 6.04
Dividend Paid and CapEx Coverage Ratio
 -117.85 -10.27 -5.33 -1.46 -0.20
Capital Expenditure Coverage Ratio
 -117.85 -10.27 -5.33 -1.46 -0.20
Operating Cash Flow Coverage Ratio
 -0.90 -0.16 -0.16 -0.12 -0.07
Operating Cash Flow to Sales Ratio
 -0.19 -0.07 -0.03 -0.03 -0.01
Free Cash Flow Yield
-18.71%-5.32%-9.19%-6.46%-15.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.80 -19.51 -8.43 -12.19 -6.21
Price-to-Sales (P/S) Ratio
 1.02 1.41 0.43 0.83 0.55
Price-to-Book (P/B) Ratio
 42.38 24.48 3.40 4.77 2.60
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.34 -18.81 -10.88 -15.48 -6.50
Price-to-Operating Cash Flow Ratio
 -5.27 -20.64 -12.92 -26.09 -39.24
Price-to-Earnings Growth (PEG) Ratio
 -0.06 -0.19 0.20 0.30 0.52
Price-to-Fair Value
 42.38 24.48 3.40 4.77 2.60
Enterprise Value Multiple
 -44.15 -33.53 51.65 -190.06 -10.92
Enterprise Value
 610.94M 676.81M 247.60M 430.32M 326.19M
EV to EBITDA
 -44.15 -33.53 51.65 -190.06 -10.92
EV to Sales
 1.18 1.76 0.62 1.07 0.68
EV to Free Cash Flow
 -6.16 -23.48 -15.85 -19.90 -8.08
EV to Operating Cash Flow
 -6.21 -25.76 -18.82 -33.56 -48.80
Tangible Book Value Per Share
 <0.01 <0.01 0.03 0.03 0.05
Shareholders’ Equity Per Share
 <0.01 0.01 0.03 0.04 0.05
Tax and Other Ratios
Effective Tax Rate
 >-0.01 <0.01 0.09 0.02 <0.01
Revenue Per Share
 0.25 0.22 0.21 0.21 0.25
Net Income Per Share
 -0.04 -0.02 -0.01 -0.01 -0.02
Tax Burden
 0.80 0.73 1.68 1.14 0.94
Interest Burden
 6.42 1.35 1.76 1.36 1.14
Research & Development to Revenue
 0.00 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.10 0.09 0.05 0.07 0.07
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 15.31 0.72 0.75 0.48 0.15
Currency in CNY